Vés al contingut

Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

A Phase 2 multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.

PMID: 29748443
Revista: HAEMATOLOGICA
Any: 2018
Referència: Haematologica. 2018 Aug;103(8):1351-1358. doi: 10.3324/haematol.2017.168401. Epub 2018 May 10.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Awan, Farrukh T; Barbui, Anna M; Canales, Miguel; Di Nicola, Massimo; Dyer, Martin Js; Gianni, Alessandro M; Guidetti, Anna; Hatteville, Laurence; Janikova, Andrea; Lopez, Andres et al.
DOI: 10.3324/haematol.2017.168401

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors.

PMID: 30167089
Revista: Oncotarget
Any: 2018
Referència: Oncotarget. 2018 Aug 3;9(60):31709-31718. doi: 10.18632/oncotarget.25854. eCollection 2018 Aug 3.
Factor d'impacte: 0
Tipus de publicació: Assaig clínic
Autors: Han, Yu, Rodon, Jordi, Curigliano, Giuseppe, Delord, Jean-Pierre, Harb, Wael, Azaro, Analia, Sellami, Dalila, Beck, Thaddeus, Donnet, Valerie, Wilke, Celine et al.
DOI: 10.18632/oncotarget.25854

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors.

PMID: 30167089
Revista: Oncotarget
Any: 2018
Referència: Oncotarget. 2018 Aug 3;9(60):31709-31718. doi: 10.18632/oncotarget.25854. eCollection 2018 Aug 3.
Factor d'impacte:
Tipus de publicació: Assaig clínic
Autors: Azaro, Analia; Beck, Thaddeus; Curigliano, Giuseppe; Delord, Jean-Pierre; Donnet, Valerie; Han, Yu; Harb, Wael; Rodon, Jordi; Sellami, Dalila; Wilke, Celine et al.
DOI: 10.18632/oncotarget.25854

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

PMID: 29128908
Revista: Targeted Oncology
Any: 2018
Referència: Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z.
Factor d'impacte: 3.877
Tipus de publicació: Article en revista internacional
Autors: Alsina, Maria, Rivera, Fernando, Ramos, Francisco Javier, Galan, Maica, Lopez, Rafael, Garcia-Alfonso, Pilar, Ales-Martinez, Jose Enrique, Queralt, Bernardo, Anton, Antonio, Carrato, Alfredo et al.
DOI: 10.1007/s11523-017-0536-z

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

PMID: 29128908
Revista: Targeted Oncology
Any: 2018
Referència: Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ales-Martinez, Jose Enrique; Alsina, Maria; Anton, Antonio; Aranda, Enrique; Carrato, Alfredo; de Mena, Inmaculada Ruiz; Galan, Maica; Garcia-Alfonso, Pilar; Giralt, Jordi; Gravalos, Cristina et al.
DOI: 10.1007/s11523-017-0536-z

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

PMID: 29392425
Revista: ANNALS OF HEMATOLOGY
Any: 2018
Referència: Ann Hematol. 2018 May;97(5):763-772. doi: 10.1007/s00277-018-3229-5. Epub 2018 Feb 2.
Factor d'impacte: 2.845
Tipus de publicació: Article en revista internacional
Autors: Cordon, Lourdes, Martinez-Cuadron, David, Boluda, Blanca, Martinez, Pilar, Bergua, Juan, Rodriguez-Veiga, Rebeca, Esteve, Jordi, Vives, Susana, Serrano, Josefina, Vidriales, Belen et al.
DOI: 10.1007/s00277-018-3229-5

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

PMID: 29392425
Revista: ANNALS OF HEMATOLOGY
Any: 2018
Referència: Ann Hematol. 2018 May;97(5):763-772. doi: 10.1007/s00277-018-3229-5. Epub 2018 Feb 2.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Benavente, Celina; Bergua, Juan; Boluda, Blanca; Cordon, Lourdes; Diaz-Beya, Marina; Esteve, Jordi; Fernandez, Pau Montesinos; Garrido, Ana; Jimenez-Ubieto, Ana; Martinez, Pilar et al.
DOI: 10.1007/s00277-018-3229-5

A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.

PMID: 29681434
Revista: Clinical Lung Cancer
Any: 2018
Referència: Clin Lung Cancer. 2018 Sep;19(5):e567-e574. doi: 10.1016/j.cllc.2018.03.016. Epub 2018 Mar 23.
Factor d'impacte: 4.204
Tipus de publicació: Article en revista internacional
Autors: Waqar, Saiama N, Martinez-Marti, Alex, Ponce, Santiago, Zhen, Huiling, Kennealey, Gerard, Erickson-Viitanen, Susan, Schaefer, Eric, Sanborn, Rachel E, Giaccone, Giuseppe et al.
DOI: 10.1016/j.cllc.2018.03.016

A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.

PMID: 29681434
Revista: Clinical Lung Cancer
Any: 2018
Referència: Clin Lung Cancer. 2018 Sep;19(5):e567-e574. doi: 10.1016/j.cllc.2018.03.016. Epub 2018 Mar 23.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Erickson-Viitanen, Susan; Giaccone, Giuseppe; Kennealey, Gerard; Martinez-Marti, Alex; Ponce, Santiago; Sanborn, Rachel E; Schaefer, Eric; Waqar, Saiama N; Zhen, Huiling et al.
DOI: 10.1016/j.cllc.2018.03.016

A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE.

PMID: 29408350
Revista: CLINICAL MICROBIOLOGY AND INFECTION
Any: 2018
Referència: Clin Microbiol Infect. 2018 Oct;24(10):1102.e7-1102.e15. doi: 10.1016/j.cmi.2018.01.019. Epub 2018 Mar 3.
Factor d'impacte: 5.394
Tipus de publicació: Article en revista internacional
Autors: Aznar, Maria L, de Alarcon, Aristides, Garcia-Cabrera, Emilio, Galvez-Acebal, Juan, Sanchez-Espin, Gemma, Reguera-Iglesias, Jose M, De La Torre-Lima, Javier, Lomas, Jose M, Hidalgo-Tenorio, Carmen, Vallejo, Nuria et al.
DOI: 10.1016/j.cmi.2018.01.019

A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE.

PMID: 29408350
Revista: CLINICAL MICROBIOLOGY AND INFECTION
Any: 2018
Referència: Clin Microbiol Infect. 2018 Oct;24(10):1102.e7-1102.e15. doi: 10.1016/j.cmi.2018.01.019. Epub 2018 Mar 3.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Almirante, Benito; Aznar, Maria L; Castro, Miguel A; de Alarcon, Aristides; De La Torre-Lima, Javier; Fernandez-Hidalgo, Nuria; Ferreria-Gonzalez, Ignacio; Galvez-Acebal, Juan; Garcia-Cabrera, Emilio; Garcia-Dorado, David et al.
DOI: 10.1016/j.cmi.2018.01.019

A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE (CLM-17-12757).

PMID: 30223027
Revista: CLINICAL MICROBIOLOGY AND INFECTION
Any: 2018
Referència: Clin Microbiol Infect. 2018 Dec;24(12):1354. doi: 10.1016/j.cmi.2018.09.002. Epub 2018 Sep 15.
Factor d'impacte: 5.394
Tipus de publicació: Carta o abstract
Autors: Ferreira-Gonzalez, I, Fernandez-Hidalgo, N, Ribera, A et al.
DOI: 10.1016/j.cmi.2018.09.002

A pragmatic approach for mortality prediction after surgery in infective endocarditis: Optimizing and refining EuroSCORE (CLM-17-12757).

PMID: 30223027
Revista: CLINICAL MICROBIOLOGY AND INFECTION
Any: 2018
Referència: Clin Microbiol Infect. 2018 Dec;24(12):1354. doi: 10.1016/j.cmi.2018.09.002. Epub 2018 Sep 15.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Fernandez-Hidalgo, N; Ferreira-Gonzalez, I; Ribera, A et al.
DOI: 10.1016/j.cmi.2018.09.002

A Previously Unrecognized Ca(2+)-inhibited Nonselective Cation Channel in Red Blood Cells.

PMID: 30887009
Revista: HemaSphere
Any: 2018
Referència: Hemasphere. 2018 Oct;2(5):e146. doi: 10.1097/HS9.0000000000000146. Epub 2018 Oct 2.
Factor d'impacte: 0
Tipus de publicació: Article en revista internacional
Autors: Petkova-Kirova, Polina, Hertz, Laura, Makhro, Asya, Danielczok, Jens, Huisjes, Rick, Llaudet-Planas, Esther, Manu-Pereira, Maria Del Mar, Vives Corrons, Joan-Luis, van Wijk, Richard, Bogdanova, Anna et al.
DOI: 10.1097/HS9.0000000000000146

A Previously Unrecognized Ca(2+)-inhibited Nonselective Cation Channel in Red Blood Cells.

PMID: 30887009
Revista: HemaSphere
Any: 2018
Referència: Hemasphere. 2018 Oct;2(5):e146. doi: 10.1097/HS9.0000000000000146. Epub 2018 Oct 2.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Bogdanova, Anna; Danielczok, Jens; Hertz, Laura; Huisjes, Rick; Kaestner, Lars; Llaudet-Planas, Esther; Makhro, Asya; Manu-Pereira, Maria Del Mar; Petkova-Kirova, Polina; van Wijk, Richard et al.
DOI: 10.1097/HS9.0000000000000146

A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study.

PMID: 29218379
Revista: INTENSIVE CARE MEDICINE
Any: 2018
Referència: Intensive Care Med. 2018 Jan;44(1):22-37. doi: 10.1007/s00134-017-4996-5. Epub 2017 Dec 7.
Factor d'impacte: 15.008
Tipus de publicació: Article en revista internacional
Autors: Durand, Michel, Assiri, A H, Mainas, E, Hasan, M S, Morocho-Tutillo, D R, Baboi, L, Chretien, J M, Francois, G, Ayzac, L, Chen, L et al.
DOI: 10.1007/s00134-017-4996-5

A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study.

PMID: 29218379
Revista: INTENSIVE CARE MEDICINE
Any: 2018
Referència: Intensive Care Med. 2018 Jan;44(1):22-37. doi: 10.1007/s00134-017-4996-5. Epub 2017 Dec 7.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Adam, J F; Al Bshabshe, Ali; Alban, Laura; Albiero, Daniela; Almekhlafi, Ghaleb; Alqdah, M; Amal, Jean-Michel; Anwar, Sibs; Araujo, Ana Carolina; Arbelot, Charlotte et al.
DOI: 10.1007/s00134-017-4996-5

A questionnaire survey of radiological diagnosis and management of renal dysplasia in children.

PMID: 28647851
Revista: JOURNAL OF NEPHROLOGY
Any: 2018
Referència: J Nephrol. 2018 Feb;31(1):95-102. doi: 10.1007/s40620-017-0417-7. Epub 2017 Jun 24.
Factor d'impacte: 2.724
Tipus de publicació: Article en revista internacional
Autors: Montini, Giovanni, Busutti, Marco, Yalcinkaya, Fatos, Woolf, Adrian S, Weber, Stefanie, Alpay, Harika, Ariceta, Gema, Bael, An, Bonthuis, Marjolein, Caliskan, Salim et al.
DOI: 10.1007/s40620-017-0417-7

A questionnaire survey of radiological diagnosis and management of renal dysplasia in children.

PMID: 28647851
Revista: JOURNAL OF NEPHROLOGY
Any: 2018
Referència: J Nephrol. 2018 Feb;31(1):95-102. doi: 10.1007/s40620-017-0417-7. Epub 2017 Jun 24.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alpay, Harika; Antic, Amira Peco; Ariceta, Gema; Bael, An; Bonthuis, Marjolein; Busutti, Marco; Caliskan, Salim; Gotsiridze, Elene; Gulleroglu, Kaan; Gunduz, Zubeyde et al.
DOI: 10.1007/s40620-017-0417-7

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

PMID: 30377213
Revista: EMBO Molecular Medicine
Any: 2018
Referència: EMBO Mol Med. 2018 Dec;10(12). pii: emmm.201809172. doi: 10.15252/emmm.201809172.
Factor d'impacte: 10.293
Tipus de publicació: Article en revista internacional
Autors: Vidal, Marc, Peg, Vicente, Serres-Creixams, Xavier, Dellaire, Graham, Simard, Jacques, Nuciforo, Paolo, Rubio, Isabel T, Dientsmann, Rodrigo, Barrett, J Carl, Caldas, Carlos et al.
DOI: 10.15252/emmm.201809172

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

PMID: 30377213
Revista: EMBO Molecular Medicine
Any: 2018
Referència: EMBO Mol Med. 2018 Dec;10(12). pii: emmm.201809172. doi: 10.15252/emmm.201809172.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Balmana, Judith; Barrett, J Carl; Baselga, Jose; Bonache, Sandra; Bruna, Alejandra; Cairo, Stefano; Caldas, Carlos; Castroviejo-Bermejo, Marta; Cortes, Javier; Cruz, Cristina et al.
DOI: 10.15252/emmm.201809172

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.

PMID: 29228091
Revista: ANNALS OF ONCOLOGY
Any: 2018
Referència: Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772.
Factor d'impacte: 13.926
Tipus de publicació: Guia clínica
Autors: Gennari, A, Sun, Z, Hasler-Strub, U, Colleoni, M, Kennedy, M J, Von Moos, R, Cortes, J, Vidal, M J, Hennessy, B, Walshe, J et al.
DOI: 10.1093/annonc/mdx772

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.

PMID: 29228091
Revista: ANNALS OF ONCOLOGY
Any: 2018
Referència: Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772.
Factor d'impacte:
Tipus de publicació: Guia clínica
Autors: Barbeaux, A; Bernhard, J; Borstnar, S; Colleoni, M; Cortes, J; Gennari, A; Hasler-Strub, U; Hennessy, B; Jerusalem, G; Kennedy, M J et al.
DOI: 10.1093/annonc/mdx772

A rare cause of primary adrenal insufficiency due to a homozygous Arg188Cys mutation in the STAR gene.

PMID: 29576868
Revista: Endocrinology, diabetes & metabolism case repo
Any: 2018
Referència: Endocrinol Diabetes Metab Case Rep. 2018 Mar 21;2018. pii: EDM180003. doi: 10.1530/EDM-18-0003. eCollection 2018.
Factor d'impacte: 0
Tipus de publicació: Article en revista internacional
Autors: Henzen, Christoph, Burget, Lukas, Parera, Laura Audi, Fernandez-Cancio, Monica, Grani, Rolf, Fluck, Christa E et al.
DOI: 10.1530/EDM-18-0003